RMOC Hydroxychloroquine retinopathy monitoring: Consultation running until 13/11/2020

RMOC South is inviting comments on the content of draft guidance which addresses how to keep patients safe from the risk of retinopathy during long term hydroxychloroquine therapy for inflammatory diseases.

Specialist Pharmacy Service